Cancer vs. COVID: When a Pandemic Upended Cancer Care

A Rogel Cancer Center team created a guide to help providers navigate difficult conversations due to the coronavirus.

9:19 AM

Author | Nicole Fawcett

patient with mask on looking at doctor in exam room with mask on standing
A Michigan Medicine oncology team put together examples of language that doctors could use to respond to patients empathetically. Photo by Michigan Medicine.

Editor's note: Information on the COVID-19 crisis is constantly changing. For the latest numbers and updates, keep checking the CDC's website. For the most up-to-date information from Michigan Medicine, visit the hospital's Coronavirus (COVID-19) webpage

Interested in a COVID-19 clinical trial? Health research is critical to ending the COVID-19 pandemic. Our researchers are hard at work to find vaccines and other ways to potentially prevent and treat the disease and need your help. Sign up to be considered for a clinical trial at Michigan Medicine.

When COVID-19 struck, health care pivoted hard. Any unnecessary procedures or appointments were postponed. For people with cancer, that pivot was particularly shattering.

"COVID-19 changed the face of health care in the United States virtually overnight. Oncologists were discussing with their patients whether the benefit of coming in for treatment outweighed the risk of being exposed to the virus in the health care setting," says Laila A. Gharzai, M.D., LLM, a radiation oncology resident at Michigan Medicine.

"It was a challenging shift for physicians, and we personally wanted some help navigating these conversations," she says.

In response, Gharzai and colleagues interviewed eight physicians to identify specific communication challenges related to COVID-19 and surveyed 48 patients to get their perspective.

They identified three core communication strategies and applied them to eight specific scenarios impacting patients, including concerns around risk of COVID-19, delays in testing or treatment, changes to treatment and follow up care. Informed by the communication strategies, the team created examples of language that oncologists could use to respond to patients empathetically. Their results are published in JAMA Oncology.

"What impacted me most was hearing just how tough these conversations were. As oncologists, we are used to having tough conversations with our patients. COVID-related conversations took this to a whole other level, by incorporating a new challenge of having to view all of our decisions with a public health lens. This guide was important to give providers a quick resource when they needed it most," Gharzai says.

SEE ALSO: App Calculates Risk of Delaying Cancer Care During Pandemic

Patients' concerns ranged from their risk of getting coronavirus to fears that a delayed test could miss a growing cancer. Many patients felt they were being punished or ignored, as if their health needs were less important. And while the decisions were all made with a view toward keeping patients safe from the greater threat of COVID-19, cancer is not used to taking a backseat.

"Patients are understandably emotional when they receive a cancer diagnosis, even under normal circumstances. This emotional response was amplified by the stress of changes due to the pandemic," says Reshma Jagsi, M.D., D.Phil., Newman Family Professor and deputy chair of radiation oncology at Michigan Medicine and senior author on the paper.

"The practical language in the guide really helped me to reassure patients that I recognized their very appropriate emotions, that I care deeply about them, and that I was going to try to help," she says.

The team published their guidelines online in April, when COVID-19 was peaking in Michigan. It remains available to providers.

Kenneth Resnicow, Ph.D., and Lawrence C. An, M.D., are co-authors on the paper.

Paper cited: "Perspectives on Oncology-Specific Language During the Coronavirus Disease 2019 Pandemic: A Qualitative Analysis," JAMA Oncology. DOI: 10.1001/jamaoncol.2020.2980


More Articles About: Rounds Cancer Research Covid-19 Cancer: Cancer Types Health Care Delivery, Policy and Economics Cancer: Help, Diagnosis & Treatment
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

MichmedMedia@med.umich.edu

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories hand holding older hand over blanket
Health Lab
What experts wish more people knew about hospice and other end-of-life care
Hospice, palliative care, end-of-life decisions, long-term care insurance and durable power of attorney are all things people with serious health issues should think about.
friends adults thanksgiving dinner table
Health Lab
How to safely celebrate the holidays and avoid getting sick
This holiday season, follow these five expert-approved steps to celebrate safely and avoid getting sick.
PURPLE BLUE RED CELLS FLOATING
Health Lab
Using cellular therapy to treat cancer, and beyond
Here, Monalisa Ghosh, M.D., a hematologist-oncologist at the University of Michigan Health Rogel Cancer Center, answers questions about cellular therapy; how it's used and what exciting developments are soon to come.
out the window woman staring
Health Lab
1 in 3 older adults still experience loneliness and isolation
Rates of loneliness and social isolation in older people have declined from pandemic highs, but are still a problem especially for those with mental or physical health issues or disabilities.
bone close up of cells inside green bbble with cells inside in yellow brown pink and red orange background
Health Lab
How breast cancer cells survive in bone marrow after remission
A new study from researchers at the University of Michigan and the University of California San Diego has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies.
patient looking at paper with provider in scrubs blue in clinic
Health Lab
How race impacts patients’ response to cancer immunotherapy
The first large scale analysis finds immune checkpoint inhibitors are equally effective in Black and white patients, with Black patients having fewer side effects.